Sagimet Biosciences Inc. - Enterprise Value

The Enterprise Value as of July 2026 (TTM) for Sagimet Biosciences Inc. (SGMT) is 192.79M

According to Sagimet Biosciences Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 192.79M. This represents a change of 12.79% compared to the average of 170.93M of the last 4 quarters.

Sagimet Biosciences Inc. (SGMT) Historical Enterprise Value (quarterly & annually)

How has SGMT Enterprise Value performed in the past?

The mean historical Enterprise Value of Sagimet Biosciences Inc. over the last ten years is 217.92M. The current 192.79M Enterprise Value has changed 8.75% with respect to the historical average. Over the past ten years (40 quarters), SGMT's Enterprise Value was at its highest in in the December 2022 quarter at 353.73M. The Enterprise Value was at its lowest in in the March 2024 quarter at -24874796.79.

Sagimet Biosciences Inc. (SGMT) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Sagimet Biosciences Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Sagimet Biosciences Inc. (SGMT) Average Enterprise Value

How has SGMT Enterprise Value performed in the past?

The current Enterprise Value of Sagimet Biosciences Inc. (SGMT) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Sagimet Biosciences Inc. (SGMT) Enterprise Value vs. Peers

How is SGMT’s Enterprise Value compared to its peers?

Sagimet Biosciences Inc.’s Enterprise Value is greater than Arcturus Therapeutics Holdings Inc. (-22818430.00), greater than Humacyte, Inc. (122.29M), less than Assembly Biosciences, Inc. (370.44M), less than Zura Bio Limited (278.84M), greater than Voyager Therapeutics, Inc. (172.52M), less than Entrada Therapeutics, Inc. (227.58M), less than Foghorn Therapeutics Inc. (231.38M), less than Immuneering Corporation (3.83B), less than Achieve Life Sciences, Inc. (620.79M), less than Atea Pharmaceuticals, Inc. (291.04M),

Build a custom stock screener for Sagimet Biosciences Inc. (SGMT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sagimet Biosciences Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sagimet Biosciences Inc. (SGMT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sagimet Biosciences Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.